title: Impact of corticotropin-releasing hormone on extracellular norepinephrine in prefrontal cortex after chronic cold stress.
abstract: We have previously demonstrated that exposing rats to cold (5 degrees C) for 3-4 weeks potentiates the increase in extracellular norepinephrine (NE) in the medial prefrontal cortex produced by acute tail shock. In the present study, we used microdialysis to determine the duration of cold exposure required to produce this sensitization and explored the mechanism of the phenomenon. Tail shock elicited a twofold greater increase in extracellular NE in the medial prefrontal cortex of rats exposed to cold for 2 weeks than in naive control rats or in rats exposed to cold for 1 week and tested either immediately or after a 2-week delay. Local infusion of 10 microM D-amphetamine or 30 mM K+ increased extracellular NE in the medial prefrontal cortex (approximately 350 and 190%, respectively) comparably in control rats and rats exposed to cold for 3 weeks. In contrast, intraventricular administration of 3.0 microg of corticotropin-releasing hormone increased extracellular NE in the medial prefrontal cortex by 65% in rats exposed to cold for 2 weeks, but only 35% in control rats. These results indicate that an enhanced responsiveness of noradrenergic neurons to acute tail shock (1) requires approximately 2 weeks of cold exposure to develop and (2) may be mediated by a change at the level of the noradrenergic cell bodies rather than the nerve terminals.
authors.affiliation: Department of Neuroscience, University of Pittsburgh, Pennsylvania 15260, U.S.A.
authors.forename: J M
authors.initials: JM
authors.lastname: Finlay
authors.forename: H P
authors.initials: HP
authors.lastname: Jedema
authors.forename: A D
authors.initials: AD
authors.lastname: Rabinovic
authors.forename: M J
authors.initials: MJ
authors.lastname: Mana
authors.forename: M J
authors.initials: MJ
authors.lastname: Zigmond
authors.forename: A F
authors.initials: AF
authors.lastname: Sved
mesh_terms: D018663:Adrenergic Agents / Q000494:pharmacology; D000661:Amphetamine / Q000494:pharmacology; D000818:Animals; D003080:Cold Temperature; D003346:Corticotropin-Releasing Hormone / Q000494:pharmacology*; D004558:Electric Stimulation; D005110:Extracellular Space / Q000378:metabolism; D007276:Injections, Intraventricular; D008297:Male; D017551:Microdialysis; D009638:Norepinephrine / Q000378:metabolism*; D011188:Potassium / Q000494:pharmacology; D017397:Prefrontal Cortex / Q000737:chemistry / Q000187:drug effects / Q000378:metabolism*; D051381:Rats; D017207:Rats, Sprague-Dawley; D013312:Stress, Physiological / Q000378:metabolism*; D013623:Tail; D013997:Time Factors
chemical_list: D018663:Adrenergic Agents; D003346:Corticotropin-Releasing Hormone; D000661:Amphetamine; D011188:Potassium; D009638:Norepinephrine